Startups
Cambridge Epigenetix has a vision to improve healthcare through routine measurement of the epigenome.
Overview
Location
United Kingdom, England, Cambridge
Employees
51-200
Total raised
$144.5M
Founded date
2012
Investors 5
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Third Point Ventures | thirdpointventures.com | |
| New Science Ventures | newscienceventures.com | |
| Ahren Innovation Capital | ahreninnovationcapital.com | |
| GV | gv.com |
Funding Rounds 4
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Apr 2, 2018 | Funding round | $30M | |
| Mar 14, 2016 | Series B round | $21M | |
| Oct 29, 2014 | Series A round | $5.5M |
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 3, 2021 | Cambridge Epigenetix raises $88m Series D financing to advance DNA sequencing technology platform | Cambridge Epigenetix raises $88m Series D financing to advance DNA sequencing technology platform 03-11-2021 Cambridge Epigenetix (CEGX), a life sciences tools and technology company revolutionising genome sequencing, has announced the sign... |
| Nov 2, 2021 | Cambridge Epigenetix Raises $88 Million Series D Financing to Advance Best-in-Class DNA Sequencing Technology Platform | Technology increases the amount and quality of data that can be efficiently and cost-effectively obtained from a small DNA sample Manufacturing of the first product from a new technology platform is underway with expected commercial availab... |
| Nov 2, 2021 | Cambridge Epigenetix Raises $88 Million Series D Financing to Advance Best-in-Class DNA Sequencing Technology Platform | Technology increases the amount and quality of data that can be efficiently and cost-effectively obtained from a small DNA sample Manufacturing of the first product from a new technology platform is underway with expected commercial availab... |
| Sep 3, 2019 | Tom Hulme from GV is joining us at Disrupt Berlin | Based in London, Tom Hulme is a general partner for GV, the VC firm formerly known as Google Ventures. And Hulme isn’t your average VC, as he likes to focus on hard problems instead of quick wins. He has become an important figure of the Eu... |
| Apr 2, 2018 | Ahren Leads $30mn Funding Round in Cambridge Epigenetix | |
| Mar 30, 2017 | SpyBiotech, which makes a ‘superglue’ for vaccines, raises £4M from GV and Oxford | The startup bug has hit the world of biotechnology, and the latest victim is a business that is building a “super glue,” coincidentally, for bug-combating vaccines. SpyBiotech — a startup spun out of Oxford University that has developed a w... |
| Mar 17, 2016 | Google’s GV leads $21M Series B in bioscience firm Cambridge Epigenetix | VC firm GV (née Google Ventures) has made another investment in Europe — its seventh — leading a $21 million Series B round for epigenetic sequencing tech company and Cambridge University spin-out, Cambridge Epigenetix. The U.K.-based biosc... |
| Mar 14, 2016 | Cambridge Epigenetix announces $21M Series B financing and appoints Dr Geoff Smith as CEO | Cambridge Epigenetix announces $21M Series B financing and appoints Dr Geoff Smith as CEO 14-03-2016 Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, today announced the close of a $21 million... |
| Mar 14, 2016 | Cambridge Epigenetix raises $21M, poaches new CEO from Illumina | Cambridge Epigenetix was cofounded by Shankar Balasubramaniam, who previously cofounded Solexa – a next generation sequencing company from Cambridge, U.K. that was acquired by Illumina in 2007. Indeed, its technology provided the basis for ... |
Show more
Reviews 0
FAQ about Cambridge Epigenetix
When was Cambridge Epigenetix founded?
Cambridge Epigenetix was founded in 2012.
How much funding has Cambridge Epigenetix raised?
Cambridge Epigenetix has raised $144.5M in total across 4 funding rounds.
What funding rounds has Cambridge Epigenetix raised?
Parsers VC lists 4 funding rounds of Cambridge Epigenetix, among them a funding round of $30M on Apr 2, 2018, a Series B round of $21M on Mar 14, 2016 and a Series A round of $5.5M on Oct 29, 2014.
Who has invested in Cambridge Epigenetix?
Parsers VC lists 5 investors of Cambridge Epigenetix, among them Third Point Ventures, New Science Ventures and Ahren Innovation Capital.
What has the press written about Cambridge Epigenetix?
Parsers VC has collected 17 articles mentioning Cambridge Epigenetix, among them “Cambridge Epigenetix raises $88m Series D financing to advance DNA sequencing technology platform” (Nov 3, 2021) and “Cambridge Epigenetix Raises $88 Million Series D Financing to Advance Best-in-Class DNA Sequencing Technology Platform” (Nov 2, 2021).
Is Cambridge Epigenetix still active?
Yes, Cambridge Epigenetix is active; its latest activity on Parsers VC dates from Nov 3, 2021.